The estimated Net Worth of Heather D. Rider is at least $294 Tysiąc dollars as of 6 September 2018. Ms. Rider owns over 2,250 units of Inogen Inc stock worth over $49,003 and over the last 10 years she sold INGN stock worth over $0. In addition, she makes $245,022 as Independent Director at Inogen Inc.
Heather has made over 4 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 2,250 units of INGN stock worth $97,223 on 6 September 2018.
The largest trade she's ever made was exercising 5,222 units of Inogen Inc stock on 26 February 2018 worth over $171,699. On average, Heather trades about 606 units every 66 days since 2014. As of 6 September 2018 she still owns at least 4,239 units of Inogen Inc stock.
You can see the complete history of Ms. Rider stock trades at the bottom of the page.
Heather D. Rider is an Independent Director of the Company. From 2012 to 2013, Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012, Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc., a publicly-traded medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010, she served as Vice President, Human Resources of Intuitive Surgical, Inc., a publicly-traded manufacturer of robotic surgical systems. From 2001 to 2005, Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001, Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer of intracardiac catheters and location technology. Prior to 1998, Ms. Rider served as Head of Human Resources for City of Hope, a leading research and treatment center for cancer, diabetes and other life-threatening diseases, CAP/MPT, a medical malpractice provider for physicians in California and medical malpractice insurance for large physician groups and hospitals, and Environmental Diagnostics International, a bio-diagnostics company with focus on the detection of environmental compounds and diseases using monoclonal antibody technology. Ms. Rider currently serves on the Board of Directors of Intricon Corporation, a medical technology company. Ms. Rider holds a Bachelor of Arts in Psychology from Claremont McKenna College and an M.B.A. from Pepperdine University. The Board believes that she is qualified to serve as a director of Inogen because of her extensive executive-level experience with healthcare and life science companies.
As the Independent Director of Inogen Inc, the total compensation of Heather Rider at Inogen Inc is $245,022. There are 9 executives at Inogen Inc getting paid more, with Scott Wilkinson having the highest compensation of $2,520,530.
Heather Rider is 60, she's been the Independent Director of Inogen Inc since 2014. There are 5 older and 14 younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.
Heather's mailing address filed with the SEC is C/O INOGEN, INC., 859 WARD DRIVE, GOLETA, CA, 93111.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen oraz Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: